Circulating HSPCs enhance their self-renewal by augmenting the endocytosis and lysosomal acidity via MIF-(CXCR4_CD74)-ATP6V1A axis
Abstract
Abstract Human circulating hematopoietic stem/progenitor cells (cHSPCs) in steady-state blood are a rare, underutilized resource limited by poor ex vivo expansion and unclear regulation. Using an immune-cell screening platform, we found that monocytes most effectively promote cHSPC expansion while preserving long-term hematopoietic reconstitution in serial transplantation. Mechanistically, cHSPCs engage the MIF-(CXCR4_CD74)-ATP6V1A axis to enhance endocytosis and lysosomal acidification, which upregulates CD34 + CXCR4 + cells, reduces ROS, stabilizes HIF-1α, and maintains glycolytic activity and stemness. Monocyte co-culture or pathway agonizts (MIF, EN6) also expanded HSPCs from cord blood, bone marrow, and poor-graft-function patient samples. Thus, cHSPC self-renewal is driven by an MIF-(CXCR4_CD74)-ATP6V1A-dependent mechanism modulating endocytosis, lysosomal function, and metabolism. This offers a universal expansion strategy for diverse clinical sources, including steady-state peripheral blood, cord blood, and functionally compromised hematopoietic cells.
// Source
Authors: Yulin Xu, Jianghuan Lu, Meng Zhang, Yuanyin Teng, Xinyan Wang, Xiaoyu Lai, Dawei Huo, 帖儒修, Xiangjun Zeng, Yijin Chen, Wei Shan, Ce Shi, Rui Wen, 姜蓬垒, Honghu Li, 于晓红, Shanshan Pei, Pengxu Qian, He Huang
Institutions: First Affiliated Hospital Zhejiang University, Zhejiang University